Figure 3.
Subgroup analyses of 10-year overall survival between TACE plus sorafenib treatment or TACE alone groups. TACE: Transarterial chemoembolization
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.